Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration
Nutrients · 11.07.2024 · 16 (14) · 2223
DOI: 10.3390/nu16142223 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 11.07.2024. Verfasst von Houda Bougrine und 7 weiteren Autor:innen. Beteiligte Einrichtung: High Institute of Sport and Physical Education Gafsa, University of Gafsa, Gafsa 2100, Tunisia. Hauptthemen laut MEDLINE: Caffeine, Athletic Performance, Athletes. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
While previous studies have explored a range of factors governing the optimal use of caffeine (CAF) in athletes, limited research has explored how time of day (TOD) affects the ergogenic effects of various CAF dosages on physical performance. This study aimed to increase knowledge about how different recommended CAF doses (3 mg/kg vs. 6 mg/kg) ingested at different TODs affected maximal high-intensity physical performance and the perception of potential side effects in female athletes. In this double-blind, randomized, and counterbalanced study, 15 low CAF consumer athletes (aged 18.3 ± 0.5 y) underwent six trials, including three testing conditions assessed across two TODs: one in the morning (08:00 a.m.) and one in the evening (06:00 p.m.). During each condition, the participants ingested either a placebo, 3 mg/kg CAF (CAF (3 mg)), or 6 mg/kg CAF (CAF (6 mg)) capsules 60 min before each test with an in-between washout period of at least 72 h. In each trial, the participants performed a countermovement jumps test (CMJ), a modified agility t test (MATT), a repeated sprint ability (RSA), a rating of perceived exertion (RPE), and finally, a CAF side effects questionnaire. Our findings indicate the absence of an ergogenic effect on CMJ, MAT, and RSA performance in the evening after administering CAF (3 mg) or CAF (6 mg) compared to a placebo. Likewise, when CAF was ingested in the morning, there was an improvement in these performances with both CAF (3 mg) and CAF (6 mg), with greater improvement observed after CAF (6 mg). Additionally, neither the CAF dosage nor the TOD had a significant effect on the RPE. The occurrence of side effects increased significantly after the evening ingestion of CAF, particularly with a moderate dose of CAF (6 mg). Our findings indicate that the effectiveness of CAF depends on the TOD and CAF dosage. When ingested in the morning, a moderate dose of CAF (6 mg), rather than CAF (3 mg), is more effective in improving short-term physical performance without affecting CAF side effects in female athletes. Nevertheless, when ingested in the evening, neither dose was sufficient to enhance short-term physical performance, and both dosages increased the incidence of CAF side effects, particularly at a moderate dose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- High Institute of Sport and Physical Education Gafsa, University of Gafsa, Gafsa 2100, Tunisia.
- Physical Activity Research Unit, Sport and Health (UR18JS01), National Observatory of Sports, Tunis 1003, Tunisia.
- Department of Training and Movement Science, Institute of Sport Science, Johannes Gutenberg-University Mainz, 55099 Mainz, Germany.
- High Institute of Sport and Physical Education Sfax, University of Sfax, Sfax 3000, Tunisia.
- Research Laboratory, Molecular Bases of Human Pathology, LR19ES13, Faculty of Medicine of Sfax, University of Sfax, Sfax 3029, Tunisia.
- Research Laboratory, Education, Motricity, Sport and Health (EM2S), LR15JS01, High Institute of Sport and Physical Education of Sfax, University of Sfax, Sfax 3000, Tunisia.
ORCID-Profile: Achraf Ammar, Khaled Trabelsi, Piotr Żmijewski, Haitham Jahrami, Hamdi Chtourou, Nizar Souissi
Zitieren
APA
Bougrine, H., Ammar, A., Salem, A., Trabelsi, K., Żmijewski, P., Jahrami, H., Chtourou, H., & Souissi, N. (2024). Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration. Nutrients, 16(14), 2223. https://doi.org/10.3390/nu16142223
Vancouver
Bougrine H, Ammar A, Salem A, Trabelsi K, Żmijewski P, Jahrami H, et al. Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration. Nutrients. 2024;16(14):2223. doi:10.3390/nu16142223
BibTeX
@article{Bougrine2024,
author = {Bougrine, Houda and Ammar, Achraf and Salem, Atef and Trabelsi, Khaled and Żmijewski, Piotr and Jahrami, Haitham and Chtourou, Hamdi and Souissi, Nizar},
title = {Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {14},
pages = {2223},
doi = {10.3390/nu16142223}
}
EUVIMED